nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—VEGFA—brain cancer	0.69	1	CbGaD
Minocycline—CASP3—cochlea—brain cancer	0.0116	0.0837	CbGeAlD
Minocycline—SLC22A8—choroid plexus—brain cancer	0.00898	0.0649	CbGeAlD
Minocycline—CYCS—pineal body—brain cancer	0.00749	0.0541	CbGeAlD
Minocycline—CYCS—ganglion—brain cancer	0.00537	0.0388	CbGeAlD
Minocycline—CASP3—ganglion—brain cancer	0.0046	0.0332	CbGeAlD
Minocycline—CYCS—blood vessel—brain cancer	0.00427	0.0309	CbGeAlD
Minocycline—CYCS—hindbrain—brain cancer	0.00407	0.0294	CbGeAlD
Minocycline—CASP3—endothelium—brain cancer	0.00397	0.0287	CbGeAlD
Minocycline—CASP3—blood vessel—brain cancer	0.00366	0.0264	CbGeAlD
Minocycline—CASP3—hindbrain—brain cancer	0.00349	0.0252	CbGeAlD
Minocycline—IL1B—endothelium—brain cancer	0.00317	0.0229	CbGeAlD
Minocycline—IL1B—blood vessel—brain cancer	0.00292	0.0211	CbGeAlD
Minocycline—IL1B—hindbrain—brain cancer	0.00279	0.0201	CbGeAlD
Minocycline—MMP9—endothelium—brain cancer	0.00264	0.0191	CbGeAlD
Minocycline—MMP9—blood vessel—brain cancer	0.00244	0.0176	CbGeAlD
Minocycline—CYCS—brainstem—brain cancer	0.00233	0.0169	CbGeAlD
Minocycline—CYCS—telencephalon—brain cancer	0.00207	0.015	CbGeAlD
Minocycline—CASP3—brainstem—brain cancer	0.002	0.0145	CbGeAlD
Minocycline—CASP1—gonad—brain cancer	0.0018	0.013	CbGeAlD
Minocycline—CASP3—telencephalon—brain cancer	0.00177	0.0128	CbGeAlD
Minocycline—CASP1—pituitary gland—brain cancer	0.00175	0.0127	CbGeAlD
Minocycline—CYCS—gonad—brain cancer	0.00173	0.0125	CbGeAlD
Minocycline—IL1B—brainstem—brain cancer	0.0016	0.0115	CbGeAlD
Minocycline—CASP1—midbrain—brain cancer	0.00155	0.0112	CbGeAlD
Minocycline—CASP1—spinal cord—brain cancer	0.00151	0.0109	CbGeAlD
Minocycline—CYCS—midbrain—brain cancer	0.00149	0.0108	CbGeAlD
Minocycline—CASP3—gonad—brain cancer	0.00148	0.0107	CbGeAlD
Minocycline—CYCS—spinal cord—brain cancer	0.00145	0.0105	CbGeAlD
Minocycline—CASP3—pituitary gland—brain cancer	0.00145	0.0104	CbGeAlD
Minocycline—IL1B—telencephalon—brain cancer	0.00142	0.0102	CbGeAlD
Minocycline—VEGFA—telencephalon—brain cancer	0.00139	0.0101	CbGeAlD
Minocycline—CASP3—medulla oblongata—brain cancer	0.00139	0.0101	CbGeAlD
Minocycline—CASP1—endocrine gland—brain cancer	0.00136	0.00981	CbGeAlD
Minocycline—CASP1—head—brain cancer	0.00134	0.00969	CbGeAlD
Minocycline—CYCS—endocrine gland—brain cancer	0.00131	0.00944	CbGeAlD
Minocycline—CYCS—head—brain cancer	0.00129	0.00932	CbGeAlD
Minocycline—CASP3—spinal cord—brain cancer	0.00124	0.00899	CbGeAlD
Minocycline—CASP1—central nervous system—brain cancer	0.00122	0.00884	CbGeAlD
Minocycline—CASP1—cerebellum—brain cancer	0.0012	0.00864	CbGeAlD
Minocycline—CYCS—central nervous system—brain cancer	0.00118	0.00851	CbGeAlD
Minocycline—IL1B—pituitary gland—brain cancer	0.00115	0.00834	CbGeAlD
Minocycline—CYCS—cerebellum—brain cancer	0.00115	0.00832	CbGeAlD
Minocycline—VEGFA—pituitary gland—brain cancer	0.00114	0.00821	CbGeAlD
Minocycline—CASP3—endocrine gland—brain cancer	0.00112	0.00809	CbGeAlD
Minocycline—IL1B—medulla oblongata—brain cancer	0.00111	0.00805	CbGeAlD
Minocycline—CASP3—head—brain cancer	0.00111	0.00799	CbGeAlD
Minocycline—IL1B—midbrain—brain cancer	0.00102	0.00736	CbGeAlD
Minocycline—CASP3—central nervous system—brain cancer	0.00101	0.00729	CbGeAlD
Minocycline—IL1B—spinal cord—brain cancer	0.000993	0.00718	CbGeAlD
Minocycline—CASP3—cerebellum—brain cancer	0.000986	0.00712	CbGeAlD
Minocycline—VEGFA—spinal cord—brain cancer	0.000977	0.00706	CbGeAlD
Minocycline—CASP1—brain—brain cancer	0.000971	0.00702	CbGeAlD
Minocycline—CYCS—brain—brain cancer	0.000935	0.00676	CbGeAlD
Minocycline—IL1B—endocrine gland—brain cancer	0.000894	0.00646	CbGeAlD
Minocycline—IL1B—head—brain cancer	0.000883	0.00638	CbGeAlD
Minocycline—MMP9—spinal cord—brain cancer	0.000828	0.00598	CbGeAlD
Minocycline—IL1B—central nervous system—brain cancer	0.000806	0.00582	CbGeAlD
Minocycline—CASP3—brain—brain cancer	0.000801	0.00579	CbGeAlD
Minocycline—VEGFA—cerebellum—brain cancer	0.000775	0.0056	CbGeAlD
Minocycline—MMP9—endocrine gland—brain cancer	0.000745	0.00539	CbGeAlD
Minocycline—MMP9—head—brain cancer	0.000736	0.00532	CbGeAlD
Minocycline—SLC22A11—endocrine gland—brain cancer	0.000707	0.00511	CbGeAlD
Minocycline—SLC22A7—endocrine gland—brain cancer	0.00069	0.00498	CbGeAlD
Minocycline—MMP9—central nervous system—brain cancer	0.000672	0.00485	CbGeAlD
Minocycline—IL1B—brain—brain cancer	0.00064	0.00462	CbGeAlD
Minocycline—VEGFA—brain—brain cancer	0.000629	0.00455	CbGeAlD
Minocycline—ALOX5—endocrine gland—brain cancer	0.000589	0.00426	CbGeAlD
Minocycline—ALOX5—head—brain cancer	0.000582	0.0042	CbGeAlD
Minocycline—MMP9—brain—brain cancer	0.000533	0.00385	CbGeAlD
Minocycline—ALOX5—central nervous system—brain cancer	0.000531	0.00384	CbGeAlD
Minocycline—ALOX5—cerebellum—brain cancer	0.000519	0.00375	CbGeAlD
Minocycline—SLC22A7—brain—brain cancer	0.000493	0.00356	CbGeAlD
Minocycline—SLC22A6—brain—brain cancer	0.000476	0.00344	CbGeAlD
Minocycline—ALOX5—brain—brain cancer	0.000422	0.00305	CbGeAlD
Minocycline—SLC22A8—head—brain cancer	0.000393	0.00284	CbGeAlD
Minocycline—SLC22A8—central nervous system—brain cancer	0.000359	0.0026	CbGeAlD
Minocycline—SLC22A8—brain—brain cancer	0.000285	0.00206	CbGeAlD
Minocycline—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000122	0.000713	CbGpPWpGaD
Minocycline—CYCS—Metabolism—BSG—brain cancer	0.000122	0.000713	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MYC—brain cancer	0.000121	0.000706	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—VEGFA—brain cancer	0.000121	0.000706	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—brain cancer	0.00012	0.000699	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000119	0.000697	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000119	0.000696	CbGpPWpGaD
Minocycline—CASP1—Immune System—SKP2—brain cancer	0.000119	0.000694	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL2—brain cancer	0.000119	0.000692	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—EGFR—brain cancer	0.000118	0.00069	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—OR4C12—brain cancer	0.000117	0.000683	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—OR14C36—brain cancer	0.000117	0.000683	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000116	0.000678	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—brain cancer	0.000116	0.000675	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CCND1—brain cancer	0.000116	0.000675	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—ERBB2—brain cancer	0.000113	0.000663	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000113	0.000661	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TRPC6—brain cancer	0.000113	0.000658	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000112	0.000655	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IRS2—brain cancer	0.000112	0.000653	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—SPP1—brain cancer	0.000111	0.000647	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—brain cancer	0.00011	0.00064	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—MYC—brain cancer	0.00011	0.00064	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—brain cancer	0.000109	0.000638	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—brain cancer	0.000109	0.000636	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTCH2—brain cancer	0.000109	0.000634	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—SIRT1—brain cancer	0.000108	0.00063	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—CTNNB1—brain cancer	0.000107	0.000628	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000107	0.000626	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CCNE1—brain cancer	0.000107	0.000622	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—brain cancer	0.000106	0.000622	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000106	0.000617	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HES5—brain cancer	0.000105	0.000614	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000105	0.000614	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	0.000105	0.000613	CbGpPWpGaD
Minocycline—CYCS—Metabolism—IDH1—brain cancer	0.000105	0.000613	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—STAT3—brain cancer	0.000104	0.000609	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—SOD2—brain cancer	0.000104	0.000606	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STRADA—brain cancer	0.000102	0.000597	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—OR4C12—brain cancer	0.000102	0.000593	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—OR14C36—brain cancer	0.000102	0.000593	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—CTNNB1—brain cancer	0.000101	0.000592	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—MYC—brain cancer	0.000101	0.000588	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PIK3CG—brain cancer	9.99e-05	0.000583	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DTX2—brain cancer	9.95e-05	0.000581	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	9.95e-05	0.000581	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—brain cancer	9.93e-05	0.00058	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.87e-05	0.000577	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—EGFR—brain cancer	9.85e-05	0.000575	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TRPC6—brain cancer	9.78e-05	0.000571	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TRPC6—brain cancer	9.59e-05	0.00056	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—VEGFA—brain cancer	9.44e-05	0.000552	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—STAT3—brain cancer	9.35e-05	0.000546	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—RELA—brain cancer	9.34e-05	0.000545	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—ERBB2—brain cancer	9.28e-05	0.000542	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—MYC—brain cancer	9.27e-05	0.000541	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—MYC—brain cancer	9.11e-05	0.000532	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	9.08e-05	0.000531	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—EGFR—brain cancer	9.07e-05	0.00053	CbGpPWpGaD
Minocycline—CASP1—Immune System—VAV1—brain cancer	9.06e-05	0.000529	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—brain cancer	9e-05	0.000526	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—EGFR—brain cancer	8.91e-05	0.00052	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.89e-05	0.000519	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—TRPC6—brain cancer	8.86e-05	0.000517	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	8.85e-05	0.000517	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP2C9—brain cancer	8.84e-05	0.000516	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—brain cancer	8.82e-05	0.000515	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—STAT3—brain cancer	8.65e-05	0.000505	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DTX2—brain cancer	8.64e-05	0.000504	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—RELA—brain cancer	8.6e-05	0.000502	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ABR—brain cancer	8.52e-05	0.000498	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ENO2—brain cancer	8.29e-05	0.000484	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—brain cancer	8.27e-05	0.000483	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CCND1—brain cancer	8.24e-05	0.000481	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GLI2—brain cancer	8.23e-05	0.000481	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDK4—brain cancer	8.16e-05	0.000476	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	8.16e-05	0.000476	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	8.04e-05	0.000469	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CTNNB1—brain cancer	7.95e-05	0.000464	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—EGFR—brain cancer	7.86e-05	0.000459	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—ERBB2—brain cancer	7.76e-05	0.000453	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2—brain cancer	7.74e-05	0.000452	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GLI1—brain cancer	7.74e-05	0.000452	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	7.72e-05	0.000451	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—RELA—brain cancer	7.71e-05	0.000451	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—ERBB2—brain cancer	7.67e-05	0.000448	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—brain cancer	7.61e-05	0.000445	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTCH2—brain cancer	7.54e-05	0.00044	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—BSG—brain cancer	7.52e-05	0.000439	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—brain cancer	7.48e-05	0.000437	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.46e-05	0.000436	CbGpPWpGaD
Minocycline—IL1B—Immune System—SKP2—brain cancer	7.43e-05	0.000434	CbGpPWpGaD
Minocycline—CASP1—Immune System—PDGFRA—brain cancer	7.42e-05	0.000433	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SUFU—brain cancer	7.34e-05	0.000429	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HES5—brain cancer	7.3e-05	0.000427	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HES1—brain cancer	7.26e-05	0.000424	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—VAV1—brain cancer	7.19e-05	0.00042	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—brain cancer	7.14e-05	0.000417	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STRADA—brain cancer	7.09e-05	0.000414	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GFAP—brain cancer	7.08e-05	0.000413	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—STAT3—brain cancer	7.08e-05	0.000413	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CCND1—brain cancer	6.85e-05	0.0004	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.82e-05	0.000399	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CTNNB1—brain cancer	6.79e-05	0.000396	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.76e-05	0.000395	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	6.75e-05	0.000394	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HEY1—brain cancer	6.71e-05	0.000392	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CTNNB1—brain cancer	6.71e-05	0.000392	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MYC—brain cancer	6.61e-05	0.000386	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DLL1—brain cancer	6.58e-05	0.000384	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTCH2—brain cancer	6.55e-05	0.000382	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—STAT3—brain cancer	6.52e-05	0.000381	CbGpPWpGaD
Minocycline—CASP1—Immune System—IRS2—brain cancer	6.51e-05	0.00038	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—IDH1—brain cancer	6.47e-05	0.000378	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—brain cancer	6.46e-05	0.000377	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—brain cancer	6.43e-05	0.000376	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HES5—brain cancer	6.34e-05	0.00037	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HES1—brain cancer	6.3e-05	0.000368	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN2A—brain cancer	6.24e-05	0.000364	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2—brain cancer	6.23e-05	0.000364	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STRADA—brain cancer	6.15e-05	0.000359	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—RELA—brain cancer	6e-05	0.00035	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ABR—brain cancer	5.92e-05	0.000346	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—ERBB2—brain cancer	5.83e-05	0.000341	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GLI2—brain cancer	5.72e-05	0.000334	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CDK4—brain cancer	5.69e-05	0.000332	CbGpPWpGaD
Minocycline—IL1B—Immune System—VAV1—brain cancer	5.66e-05	0.000331	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	5.64e-05	0.000329	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SHH—brain cancer	5.6e-05	0.000327	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.47e-05	0.00032	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—brain cancer	5.43e-05	0.000317	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TRPC6—brain cancer	5.4e-05	0.000315	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—brain cancer	5.38e-05	0.000314	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GLI1—brain cancer	5.37e-05	0.000314	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.35e-05	0.000313	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—brain cancer	5.31e-05	0.00031	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTCH1—brain cancer	5.31e-05	0.00031	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SMO—brain cancer	5.31e-05	0.00031	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.26e-05	0.000307	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ABR—brain cancer	5.14e-05	0.0003	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ENO2—brain cancer	5.11e-05	0.000298	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SUFU—brain cancer	5.09e-05	0.000298	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—ERBB2—brain cancer	5.06e-05	0.000296	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GLI2—brain cancer	4.96e-05	0.00029	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CDK4—brain cancer	4.94e-05	0.000289	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GFAP—brain cancer	4.91e-05	0.000287	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GLI1—brain cancer	4.66e-05	0.000272	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HEY1—brain cancer	4.66e-05	0.000272	CbGpPWpGaD
Minocycline—IL1B—Immune System—PDGFRA—brain cancer	4.64e-05	0.000271	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DLL1—brain cancer	4.57e-05	0.000267	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CG—brain cancer	4.56e-05	0.000267	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—STAT3—brain cancer	4.55e-05	0.000266	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.5e-05	0.000263	CbGpPWpGaD
Minocycline—CASP1—Immune System—RELA—brain cancer	4.49e-05	0.000262	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—brain cancer	4.49e-05	0.000262	CbGpPWpGaD
Minocycline—CASP1—Immune System—ERBB2—brain cancer	4.46e-05	0.000261	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SUFU—brain cancer	4.42e-05	0.000258	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GFAP—brain cancer	4.27e-05	0.000249	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH2—brain cancer	4.24e-05	0.000248	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—RELA—brain cancer	4.19e-05	0.000245	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ERBB2—brain cancer	4.16e-05	0.000243	CbGpPWpGaD
Minocycline—IL1B—Immune System—IRS2—brain cancer	4.07e-05	0.000238	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—brain cancer	4.05e-05	0.000236	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HEY1—brain cancer	4.04e-05	0.000236	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VAV1—brain cancer	4.04e-05	0.000236	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—brain cancer	4.04e-05	0.000236	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DLL1—brain cancer	3.97e-05	0.000232	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTNNB1—brain cancer	3.91e-05	0.000228	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SHH—brain cancer	3.88e-05	0.000227	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CG—brain cancer	3.8e-05	0.000222	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TRPC6—brain cancer	3.75e-05	0.000219	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTCH1—brain cancer	3.68e-05	0.000215	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMO—brain cancer	3.68e-05	0.000215	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CTNNB1—brain cancer	3.64e-05	0.000213	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—RELA—brain cancer	3.63e-05	0.000212	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ERBB2—brain cancer	3.61e-05	0.000211	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—brain cancer	3.51e-05	0.000205	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HES1—brain cancer	3.48e-05	0.000203	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—brain cancer	3.47e-05	0.000203	CbGpPWpGaD
Minocycline—CASP1—Immune System—STAT3—brain cancer	3.41e-05	0.000199	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SHH—brain cancer	3.37e-05	0.000197	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PDGFRA—brain cancer	3.31e-05	0.000193	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TRPC6—brain cancer	3.25e-05	0.00019	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SPP1—brain cancer	3.21e-05	0.000188	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—brain cancer	3.21e-05	0.000188	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—brain cancer	3.2e-05	0.000187	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMO—brain cancer	3.2e-05	0.000187	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTCH1—brain cancer	3.2e-05	0.000187	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—STAT3—brain cancer	3.17e-05	0.000185	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CTNNB1—brain cancer	3.16e-05	0.000185	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—brain cancer	3.09e-05	0.000181	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH2—brain cancer	2.94e-05	0.000172	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IRS2—brain cancer	2.91e-05	0.00017	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—brain cancer	2.88e-05	0.000168	CbGpPWpGaD
Minocycline—IL1B—Immune System—RELA—brain cancer	2.81e-05	0.000164	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VAV1—brain cancer	2.81e-05	0.000164	CbGpPWpGaD
Minocycline—IL1B—Immune System—ERBB2—brain cancer	2.79e-05	0.000163	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—STAT3—brain cancer	2.75e-05	0.000161	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CG—brain cancer	2.57e-05	0.00015	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APC—brain cancer	2.57e-05	0.00015	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH2—brain cancer	2.56e-05	0.000149	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—brain cancer	2.53e-05	0.000148	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—brain cancer	2.5e-05	0.000146	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTNNB1—brain cancer	2.44e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—VAV1—brain cancer	2.44e-05	0.000142	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HES1—brain cancer	2.41e-05	0.000141	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CG—brain cancer	2.34e-05	0.000137	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDGFRA—brain cancer	2.3e-05	0.000134	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SPP1—brain cancer	2.23e-05	0.00013	CbGpPWpGaD
Minocycline—IL1B—Immune System—STAT3—brain cancer	2.13e-05	0.000124	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HES1—brain cancer	2.1e-05	0.000122	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—brain cancer	2.06e-05	0.00012	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IRS2—brain cancer	2.02e-05	0.000118	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RELA—brain cancer	2.01e-05	0.000117	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDGFRA—brain cancer	2e-05	0.000117	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ERBB2—brain cancer	1.99e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SPP1—brain cancer	1.94e-05	0.000113	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—brain cancer	1.93e-05	0.000113	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—brain cancer	1.81e-05	0.000106	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CG—brain cancer	1.78e-05	0.000104	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APC—brain cancer	1.78e-05	0.000104	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—brain cancer	1.76e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IRS2—brain cancer	1.75e-05	0.000102	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CTNNB1—brain cancer	1.74e-05	0.000102	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APC—brain cancer	1.55e-05	9.04e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CG—brain cancer	1.55e-05	9.04e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—brain cancer	1.54e-05	8.97e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STAT3—brain cancer	1.52e-05	8.88e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYC—brain cancer	1.41e-05	8.25e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RELA—brain cancer	1.39e-05	8.13e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ERBB2—brain cancer	1.38e-05	8.08e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—brain cancer	1.38e-05	8.07e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—brain cancer	1.25e-05	7.32e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—brain cancer	1.22e-05	7.14e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CTNNB1—brain cancer	1.21e-05	7.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RELA—brain cancer	1.21e-05	7.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ERBB2—brain cancer	1.2e-05	7.02e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—brain cancer	1.16e-05	6.78e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—brain cancer	1.09e-05	6.36e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—brain cancer	1.07e-05	6.22e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—brain cancer	1.06e-05	6.2e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT3—brain cancer	1.06e-05	6.16e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CTNNB1—brain cancer	1.05e-05	6.14e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYC—brain cancer	9.81e-06	5.73e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—brain cancer	9.59e-06	5.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT3—brain cancer	9.16e-06	5.35e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYC—brain cancer	8.51e-06	4.97e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—brain cancer	8.33e-06	4.86e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—brain cancer	8.05e-06	4.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—brain cancer	6.99e-06	4.08e-05	CbGpPWpGaD
